# Banco Vida Corp. - Inspection Records

Source: https://www.keypedia.com/companies/banco-vida-corp/6710f827-76c1-4157-8a90-93c6458c3eca

> Inspection records and compliance data for Banco Vida Corp. in San Juan, Puerto Rico. Access full analysis and detailed observations.

---

## Details

- Name: Banco Vida Corp.
- FEI Number: 3011849882
- City: San Juan
- State: Puerto Rico
- Country Name: United States
- Address Line 1: # 239, Arterial  Hostos Avenue, Capital Center Building, Torre Sur, Suite 604
- Zip Code: 00918

## Related Documents

- [FDA Inspection 1337074 - Banco Vida Corp. - 2026-09-16](https://www.keypedia.com/records/fda_inspections/banco-vida-corp/0f038e5c-b55c-475e-8d4a-fce52d3ae2e7) — classification: No Action Indicated (NAI), source: FDA, date: September 16, 2026
- [483 - Banco Vida Corp. - 2021-08-12](https://www.keypedia.com/records/483/banco-vida-corp/1e6cf7e7-12d3-4305-b407-61a5aa566ff8) — source: FDA, date: August 12, 2021
- [EIR - Banco Vida Corp. - 2021-08-12](https://www.keypedia.com/records/eir/banco-vida-corp/19d0b362-db17-47d8-9be2-13dd26cf44a1) — source: FDA, date: August 12, 2021
- [EIR - Banco Vida Corp. - 2021-08-12](https://www.keypedia.com/records/eir/banco-vida-corp/64a199b6-c746-4386-9cc2-14d86d5a1349) — source: FDA, date: August 12, 2021
- [483 - Banco Vida Corp. - 2021-08-12](https://www.keypedia.com/records/483/banco-vida-corp/fead2d6c-f4d7-4f85-b626-d362ab608582) — source: FDA, date: August 12, 2021
- [FDA Inspection 1149817 - Banco Vida Corp. - 2021-08-12](https://www.keypedia.com/records/fda_inspections/banco-vida-corp/3fe6084f-3bce-4f63-b3dc-0f4b3fb38052) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 12, 2021
- [FDA Inspection 1149817 - Banco Vida Corp. - 2021-08-12](https://www.keypedia.com/records/fda_inspections/banco-vida-corp/511591a1-e5b6-4dde-84f8-6364eb6d3ac8) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 12, 2021
- [483 - Banco Vida Corp. - 2019-09-18](https://www.keypedia.com/records/483/banco-vida-corp/7613d657-f5ac-465c-b0bc-c40c166c38da) — source: FDA, date: September 18, 2019
- [EIR - Banco Vida Corp. - 2019-09-18](https://www.keypedia.com/records/eir/banco-vida-corp/b884e390-916d-4585-a6ce-aca971b3a993) — source: FDA, date: September 18, 2019
- [483 - Banco Vida Corp. - 2019-09-18](https://www.keypedia.com/records/483/banco-vida-corp/e1632579-f12c-43e0-9526-55c89ccc4ede) — source: FDA, date: September 18, 2019
- [WARNING_LETTER - Banco Vida Corp. - 2019-09-18](https://www.keypedia.com/records/warning_letter/banco-vida-corp/a2bf2f67-4b2d-454a-9e88-0fa2e8413208) — source: FDA, date: September 18, 2019
- [WARNING_LETTER - Banco Vida Corp. - 2019-09-18](https://www.keypedia.com/records/warning_letter/banco-vida-corp/30f4c14d-0486-4d6d-a6c8-36966a0be22f) — source: FDA, date: September 18, 2019
- [FDA Inspection 1102161 - Banco Vida Corp. - 2019-09-18](https://www.keypedia.com/records/fda_inspections/banco-vida-corp/b7c6b6b6-81a9-45ca-93ab-50970e27ba52) — classification: Official Action Indicated (OAI), source: FDA, date: September 18, 2019
- [FDA Inspection 1102161 - Banco Vida Corp. - 2019-09-18](https://www.keypedia.com/records/fda_inspections/banco-vida-corp/b28debd3-afdc-4cf1-8ed2-aee9f866567f) — classification: Official Action Indicated (OAI), source: FDA, date: September 18, 2019
- [EIR - Banco Vida Corp. - 2017-12-07](https://www.keypedia.com/records/eir/banco-vida-corp/643d109e-90d7-44bd-b1c7-a6d4bfd782fb) — source: FDA, date: December 7, 2017
- [FDA Inspection 1036677 - Banco Vida Corp. - 2017-12-07](https://www.keypedia.com/records/fda_inspections/banco-vida-corp/d15bd0bd-6e23-45d9-b88e-eb4ed4a69793) — classification: No Action Indicated (NAI), source: FDA, date: December 7, 2017
- [FDA Inspection 1036677 - Banco Vida Corp. - 2017-12-07](https://www.keypedia.com/records/fda_inspections/banco-vida-corp/e7a7ddb1-82fe-4f93-a5fd-cb6b4e8fe447) — classification: No Action Indicated (NAI), source: FDA, date: December 7, 2017
- [FDA Inspection 980721 - Banco Vida Corp. - 2016-07-01](https://www.keypedia.com/records/fda_inspections/banco-vida-corp/57359fd4-52a8-49d6-a83f-5e962b282136) — classification: No Action Indicated (NAI), source: FDA, date: July 1, 2016

## Related Companies

- [Apollo Care, LLC](https://www.keypedia.com/companies/apollo-care-llc/469ed487-7a02-4eb8-beb4-474f95d475f9)
- [Wedgewood Village Pharmacy, LLC](https://www.keypedia.com/companies/wedgewood-village-pharmacy-llc/06cf5b50-fc20-475b-8be4-11a41985491e)
- [Denver Solutions, LLC DBA Leiters Health](https://www.keypedia.com/companies/denver-solutions-llc-dba-leiters-health/bda60157-b3a1-41a3-bb4f-7e3adecdd6e3)
- [Park Avenue Compounding](https://www.keypedia.com/companies/park-avenue-compounding/796f839f-10c0-4749-bac4-0c226419c3d1)
- [Akorn, Inc.](https://www.keypedia.com/companies/akorn-inc/91871042-8cde-411b-b464-09797e0b23db)
- [Avenue Pharmacy Inc dba Pathway Pharmacy](https://www.keypedia.com/companies/avenue-pharmacy-inc-dba-pathway-pharmacy/435161a3-396b-4f18-917c-ced65e1d1e3a)
- [Coastal Meds, LLC](https://www.keypedia.com/companies/coastal-meds-llc/f706471c-fa72-4716-8baa-e7d25c232a50)
- [CFP Acquisitions Inc.](https://www.keypedia.com/companies/cfp-acquisitions-inc/27cf9a06-4a99-40fd-adff-e6ca4e741871)
- [Drug Depot, LLC., dba APS Pharmacy](https://www.keypedia.com/companies/drug-depot-llc-dba-aps-pharmacy/23539db0-0aec-4b57-b283-2d629437e19c)
- [Medline Industries, Inc.](https://www.keypedia.com/companies/medline-industries-inc/8f723977-3919-46a2-a9fd-00c57f32c8bc)

## Related Officers

- [Annette Melendez](https://www.keypedia.com/people/annette-melendez/bc1a065d-6408-4c4b-9dcf-c6884e8a75c4)
- [Investigator](https://www.keypedia.com/people/irina-gaberman/c863b2de-4c64-40d2-a390-289d293e5a8f)
- [Laura E. Garcia](https://www.keypedia.com/people/laura-e-garcia/ad7c9bee-bbff-494f-b9cf-35c3a04316c0)